ATE165972T1 - 2(5h)- in position 3-substituierte furanone als ca 2+ antagonisten und entzündungshemmende mittel - Google Patents

2(5h)- in position 3-substituierte furanone als ca 2+ antagonisten und entzündungshemmende mittel

Info

Publication number
ATE165972T1
ATE165972T1 AT91907515T AT91907515T ATE165972T1 AT E165972 T1 ATE165972 T1 AT E165972T1 AT 91907515 T AT91907515 T AT 91907515T AT 91907515 T AT91907515 T AT 91907515T AT E165972 T1 ATE165972 T1 AT E165972T1
Authority
AT
Austria
Prior art keywords
substituted
arylalkyl
alkyl
inflammatory agents
aryl
Prior art date
Application number
AT91907515T
Other languages
English (en)
Inventor
Gary C M Lee
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE165972T1 publication Critical patent/ATE165972T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58—One oxygen atom, e.g. butenolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
AT91907515T 1990-04-17 1991-03-25 2(5h)- in position 3-substituierte furanone als ca 2+ antagonisten und entzündungshemmende mittel ATE165972T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/510,367 US5043457A (en) 1990-04-17 1990-04-17 2(5H)-furanones substituted in the 3 position, as Ca2+ channel antagonists and anti-inflammatory agents

Publications (1)

Publication Number Publication Date
ATE165972T1 true ATE165972T1 (de) 1998-05-15

Family

ID=24030459

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91907515T ATE165972T1 (de) 1990-04-17 1991-03-25 2(5h)- in position 3-substituierte furanone als ca 2+ antagonisten und entzündungshemmende mittel

Country Status (9)

Country Link
US (1) US5043457A (de)
EP (1) EP0525002B1 (de)
JP (1) JPH05506024A (de)
AT (1) ATE165972T1 (de)
CA (1) CA2078770A1 (de)
DE (1) DE69129408T2 (de)
ES (1) ES2116290T3 (de)
IE (1) IE911266A1 (de)
WO (1) WO1991016048A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089485A (en) * 1988-11-18 1992-02-18 Allergan, Inc. Anti-inflammatory furanones
US5171863A (en) * 1987-06-08 1992-12-15 Allergan, Inc. Intermediates for preparing 4-substituted 2-5(H)-furanones as anti-inflammatory agents
US5134128A (en) * 1987-06-08 1992-07-28 Allergan, Inc. Anti-inflammatory furanones
US5045564A (en) * 1988-12-07 1991-09-03 Allergan, Inc. Anti-inflammatory 2-furanones
US5112853A (en) * 1989-11-20 1992-05-12 Allergan, Inc. Anti-inflammatory furanone compounds
US5258400A (en) * 1989-11-20 1993-11-02 Allergan, Inc. Anti-inflammatory furanone compounds
US5183906A (en) * 1991-04-30 1993-02-02 Allergan, Inc. 2- and 5-alkyl and phenyl substituted 4-(1-hydroxy, 1-acyloxy or 1-carbamoyloxy)-5-hydroxy-2 (5h)-furanones as anti-inflammatory agents
US5225571A (en) * 1991-04-30 1993-07-06 Allergan, Inc. Substituted dihydroxy-bis-[5-hydroxy-2(5H)-furanone-4-yl]-alkanes as anti-inflammatory agents
US5171864A (en) * 1991-08-30 1992-12-15 Allergan, Inc. Di-(5-hydroxy-2(5H)-2-oxo-4-furyl)methyl-alpha,omega alkane-dioates and N,N-bis-(5-hydroxy-2(5H)-2-oxo-4-furyl)methyl-alpha,omega-dialkanoic acid amides as anti-inflammatory agents
US5169963A (en) * 1991-08-30 1992-12-08 Allergan, Inc. Di-(5-hydroxy-2(5H)2-oxo-4-furyl)alkylmethyl-alpha,omega alkanedioates and N,N-bis-(5-hydroxy-2(5H)2-oxo-4-furyl)alkylmethyl-alpha,omega-dialkanoic acid amides as anti-inflammatory agents
US5268387A (en) * 1992-04-24 1993-12-07 Allergan, Inc. Pharmaceutical compositions and method for administering 3 and 4-substituted 2(5H)-furanones to a mammal for inhibiting bone loss
US5451686A (en) * 1994-04-15 1995-09-19 Allergan, Inc. 3 and 5 alkyl and phenyl 4-(hydroxy or acyloxy)-alkyl substituted 2(5H)-furanones as anti-inflammatory agents
EP1554572B1 (de) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
ATE424448T1 (de) * 2002-10-10 2009-03-15 Merck & Co Inc Testverfahren für zustandsabhängige calciumkanal- agonisten/-antagonisten
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
CA2663377A1 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
EP2398500B1 (de) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Arzneiabgabesystem auf glutathion-basis
CA2760945A1 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2359096A (en) * 1941-03-21 1944-09-26 Lilly Co Eli beta-substituted-delta alpha, beta-gamma-butyrolactones and beta-substituted - beta - hydroxy-gamma-butyrolactones and methods of preparing them
US2359208A (en) * 1941-03-21 1944-09-26 Lilly Co Eli beta-substituted-delta alpha,beta-gamma-butyrolactones and beta-substituted-beta-hydroxy-gamma-butyrolactones and the methods of preparing them
US4447455A (en) * 1980-12-01 1984-05-08 Madaus And Company Oral urolithiasis remedy
US4616089A (en) * 1983-08-03 1986-10-07 University Of California Synthetic anti-inflammatory derivatives of manoalide
EP0133376B1 (de) * 1983-08-03 1988-07-27 The Regents Of The University Of California Synthetische analgetische und/oder antiinflammatorische Derivate des Manoalides
JPS6058973A (ja) * 1983-09-13 1985-04-05 Mitsubishi Yuka Yakuhin Kk γ−プチロラクトン誘導体及びそれを有効成分とする免疫調節剤
US4789749A (en) * 1984-06-18 1988-12-06 The Regents Of The University Of California Manoalide analogs
ZA864674B (en) * 1985-07-01 1988-02-24 Lilly Co Eli Furanone derivatives
US4786651A (en) * 1986-02-03 1988-11-22 Allergan, Inc. Treatment of cutaneous hyperproliferative dermatoses with manoalide
DE3615157A1 (de) * 1986-05-05 1987-11-12 Schwabe Willmar Gmbh & Co 5-arylalkyl-4-alkoxy-2(5h)-furanone, zwischenprodukte und verfahren zu ihrer herstellung sowie ihre anwendung als therapeutische wirkstoffe
CA1329390C (en) * 1987-06-08 1994-05-10 John N. Bonfiglio Anti-inflammatory furanones
US4916241A (en) * 1988-06-06 1990-04-10 American Home Products Corporation Inhibition of bone loss by 4-substituted-5-hydroxy-2(5H)-furanones
US4935530A (en) * 1988-10-18 1990-06-19 Allergan, Inc. Process for preparing 5-substituted-3-furaldehydes
US4957917A (en) * 1989-10-25 1990-09-18 Allergan, Inc. Anti-inflammatory furanones
US5013850A (en) * 1990-03-30 1991-05-07 Allergan, Inc. 4-ethyl and 4-ethenyl-5-hydroxy-2(5H)-furanones substituted on alpha carbon of the ethyl or ethenyl side chain with a long chain alkyl group and on the beta carbon with a polar group, as anti-inflammatory agents

Also Published As

Publication number Publication date
ES2116290T3 (es) 1998-07-16
EP0525002A4 (en) 1993-03-10
DE69129408D1 (de) 1998-06-18
IE911266A1 (en) 1991-10-23
CA2078770A1 (en) 1991-10-18
US5043457A (en) 1991-08-27
EP0525002B1 (de) 1998-05-13
WO1991016048A1 (en) 1991-10-31
EP0525002A1 (de) 1993-02-03
JPH05506024A (ja) 1993-09-02
DE69129408T2 (de) 1998-09-03

Similar Documents

Publication Publication Date Title
ATE165972T1 (de) 2(5h)- in position 3-substituierte furanone als ca 2+ antagonisten und entzündungshemmende mittel
EA199800752A1 (ru) Пентафторбензолсульфонамиды и их аналоги
TR200100075T2 (tr) 2-Kuinolon ihtiva eden farmasötik bileşimler
DE69133299D1 (de) Aminosulfonylcarbamate
BR9508901A (pt) Di-hidrobenzofurano e composto relacionados utilizáveis como agentes antiflamatórios
ATE205072T1 (de) Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung
DK0474712T3 (da) Anvendelse af lysolecitinderivater til fremstilling af et farmaceutisk præparat
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
EA200100516A1 (ru) Производные 3,3-биарилпиперидина и 2,2-биарилморфолина
TR200400857T4 (tr) Yeni galantamın türevleri ve analogları
DE3875346T2 (de) Zusammensetzungen, die mit 1-oxo- oder thiokohlenwassserstoff substituierte azacycloalkane enthalten.
SE7601143L (sv) Nytt oxadiazolinonderivat
BR9707250A (pt) Dihidrobenzofurano e compostos correlatos úteis como agentes antiinflamatórios
ES2070623T3 (es) Oxisulfonilureas inhibidoras de acat.
ATE202084T1 (de) Schwefelenthaltende di-ter-butylphenol- verbindungen brauchbar als entzündungshemmende mittel
BR9707266A (pt) Compostos dihidrobenzofurano úteis como agentes antiinflamatórios
DE69311123D1 (de) Cyclische benzylamino-, benzylamido- und benzylimido derivate als antipsychotische wirkstoffe
NO983527L (no) Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler
ATE145911T1 (de) Inositol-phosphat-analog als kalzium- antagonistische substanz
HUP0003548A2 (hu) Tachikinin receptor antagonista hatású 2-acilamino-propán-aminok és az ezeket tartalmazó gyógyszerkészítmények
TW366283B (en) Compounds for treatment of arrhythmia
ES458818A1 (es) Procedimiento para la produccion de derivados de benzofura- no.
DE59405727D1 (de) Thiocarbamoylverbindungen als mikrobizide
ES8708226A1 (es) Procedimiento para la produccion de derivados de 1,4-dihi- dropiridina